Cowen And Company, LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Cowen And Company, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 05, 2022	SELL	$234.96 - $292.55 $3.64 Million - $4.53 Million	-15,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $110,710 - $130,485	500 Added 3.33%	15,500 $804,000
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $2.66 Million - $3.35 Million	15,000 New	15,000 $337,000
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $2.96 Million - $3.49 Million	-15,800 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$207.02 - $241.31 $1.72 Million - $2 Million	8,300 Added 110.67%	15,800 $129,000
Q4 2020 Feb 08, 2021	BUY	$207.01 - $276.09 $1.55 Million - $2.07 Million	7,500 New	7,500 $18,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.